Manufacturing / Therapies / BioPharma / Biopharma / Clinical / Frontiers / Therapeutics / Medicine / Health / Events / 2018 BIO Investor Forum / BIO Investor Forum / FDA / Ruchita Sinha / Sanofi Ventures

BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

Posted on: Oct 19, 2018   |   Posted by: Biotech Mag

BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

Within the past year, the FDA has launched a provider pre-certification program as a pilot to manage the expansion of “digiceuticals” or digital therapeutics that produce...

Continue reading ...